Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency

NCT04326374 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency
Endocrine System Diseases
Hormones
Pituitary Diseases
Pituitary Disease, Anterior

Interventions

DRUG: TransCon hGH
DRUG: daily hGH

Sponsor

Visen Pharmaceuticals (Shanghai) Co., Ltd.

Collaborators

[object Object]